TrialJAMA network open2023

Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.

Xuewei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.